| # | Drug | Count |
|---|---|---|
| 0 | NILOTINIB | 840 |
| 1 | IMATINIB | 497 |
| 2 | IMATINIB MESYLATE | 444 |
| 3 | DASATINIB | 305 |
| 4 | HYDROXYUREA | 168 |
| 5 | PREDNISONE | 152 |
| 6 | PONATINIB HYDROCHLORIDE | 150 |
| 7 | BOSUTINIB | 148 |
| 8 | CYCLOPHOSPHAMIDE | 144 |
| 9 | CYCLOPHOSPHAMIDE FOR INJECTION | 144 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DASATINIB | 305 | 0.0328 |
| 1 | PONATINIB HYDROCHLORIDE | 150 | 0.0286 |
| 2 | NILOTINIB | 840 | 0.0284 |
| 3 | ASCIMINIB | 87 | 0.0249 |
| 4 | BOSUTINIB | 148 | 0.0165 |
| 5 | IMATINIB MESYLATE | 444 | 0.0160 |
| 6 | HYDROXYUREA | 168 | 0.0079 |
| 7 | BLEOMYCIN SULFATE | 37 | 0.0036 |
| 8 | ERGOCALCIFEROL | 57 | 0.0019 |
| 9 | CYTARABINE | 66 | 0.0011 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 337 |
| 1 | Kinase Inhibitor [EPC] | 307 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 193 |
| 3 | Alkylating Drug [EPC] | 184 |
| 4 | Antimetabolite [EPC] | 168 |
| 5 | Nucleoside Metabolic Inhibitor [EPC] | 164 |
| 6 | Tumor Necrosis Factor Blocker [EPC] | 161 |
| 7 | Folate Analog Metabolic Inhibitor [EPC] | 134 |
| 8 | Platelet Aggregation Inhibitor [EPC] | 128 |
| 9 | Loop Diuretic [EPC] | 119 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Enzyme Stabilizer [EPC] | 4 | 0.0034 |
| 1 | Interleukin-5 Antagonist [EPC] | 2 | 0.0029 |
| 2 | Provitamin D2 Compound [EPC] | 57 | 0.0019 |
| 3 | Glucosylceramide Synthase Inhibitor [EPC] | 5 | 0.0018 |
| 4 | Thrombopoietin Receptor Agonist [EPC] | 26 | 0.0017 |
| 5 | Hematopoietic Stem Cell Mobilizer [EPC] | 2 | 0.0013 |
| 6 | Guanylate Cyclase-C Agonist [EPC] | 2 | 0.0010 |
| 7 | Topoisomerase Inhibitor [EPC] | 61 | 0.0008 |
| 8 | Histone Deacetylase Inhibitor [EPC] | 3 | 0.0008 |
| 9 | Alkylating Drug [EPC] | 184 | 0.0008 |